EUVIMEDEUVIMED entdecken
Open Access

Gabapentinoids and Risk of Hip Fracture

Miriam T Y Leung, Justin P Turner, Clara Marquina, Jenni Ilomäki, Tim Tran, Katsiaryna Bykov, J Simon Bell

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.44488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Miriam T Y Leung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Hip Fractures, Gabapentin. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The increased use of gabapentinoids has been most pronounced in older people who are also susceptible to hip fractures.

Objective

To investigate the overall association between gabapentinoids and the risk of hip fractures and the stratified association across age groups, frailty status, and history of chronic kidney disease. Design, Setting, and Participants This was a case-case-time-control study in patients hospitalized for hip fracture in Victoria, Australia, between March 1, 2013, and June 30, 2018, with at least 1 prescription for a gabapentinoid before fracture. Conditional logistic regression was used to estimate the odds ratio (OR) and 95% CI for gabapentinoid dispensing in the index (1-60 days prefracture) compared with the reference (121-180 days prefracture) period. To adjust for the underlying time trend in gabapentinoid use, each index case was matched with up to 5 controls, selected from future cases of the same age and sex. Subgroup analyses were conducted in subgroups with or without chronic kidney disease (CKD), frailty scores less than 5, and frailty scores 5 and above. Frailty was computed using the Hospital Frailty Risk Score (HFRS). Data were analyzed from November 2023 to April 2024. Exposure Gabapentinoids (pregabalin or gabapentin). Main Outcome and Measure Hip fracture.

Results

Of 28 293 patients hospitalized for hip fractures, 2946 (1752 [59.5%] aged ≥80 years; 2099 [71.2%] female) were dispensed a gabapentinoid before hip fracture. Gabapentinoid dispensing was associated with increased odds of hip fractures (OR, 1.96; 95% CI, 1.66-2.32). After adjusting for the exposure-time trend and concomitant use of other central nervous system medications, the odds of hip fractures remained elevated (OR, 1.30; 95% CI, 1.07-1.57). The association between gabapentinoid dispensing and hip fracture was higher in patients with HFRS 5 and above (OR, 1.75; 95% CI, 1.31-2.33) and CKD (OR, 2.41; 95% CI, 1.65-3.52). Conclusions and relevance In this case-case-time-control study of Australian residents hospitalized for hip fracture, gabapentinoid use was associated with an increased risk of hip fractures, especially in patients who were frail or had chronic kidney disease. In addition to the known risk associated with kidney impairment, frailty status may be an important risk factor when considering use of gabapentinoids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hip FracturesGabapentinHumansMaleFemaleAgedAged, 80 and overCase-Control StudiesPregabalinRenal Insufficiency, ChronicVictoriaRisk FactorsFrailtyMiddle Aged

Substanzen

GabapentinPregabalin

Autor:innen und Institutionen

  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Faculty of Pharmacy, University of Montreal, Quebec City, Quebec, Canada.
  • Centre de Recherche, Institut Universitaire de Gériatrie de Montréal, Montréal, Québec, Canada.
  • Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada.
  • Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
  • Pharmacy Department, Austin Health, Melbourne, Australia.

Förderung

  • NIA NIH HHS

Zitieren

APA

Leung, M. T. Y., Turner, J. P., Marquina, C., Ilomäki, J., Tran, T., Bykov, K., & Bell, J. S. (2024). Gabapentinoids and Risk of Hip Fracture. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.44488

Vancouver

Leung MTY, Turner JP, Marquina C, Ilomäki J, Tran T, Bykov K, et al. Gabapentinoids and Risk of Hip Fracture. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.44488

BibTeX
@article{Leung2024,
  author = {Leung, Miriam T Y and Turner, Justin P and Marquina, Clara and Ilomäki, Jenni and Tran, Tim and Bykov, Katsiaryna and Bell, J Simon},
  title = {Gabapentinoids and Risk of Hip Fracture},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.44488}
}
Kostenlos starten →